quinazolines has been researched along with Lassa Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fehling, SK; Groseth, A; Hirabayashi, A; Kajikawa, J; Miyamoto, S; Muramoto, Y; Nakano, M; Noda, T; Strecker, T; Takamatsu, Y; Takenaga, T; Urata, S; Zhang, Z | 1 |
| Adhikary, S; Davey, RA; Garver, J; Johnson, L; Kolokoltsov, AA; Vela, EM | 1 |
2 other study(ies) available for quinazolines and Lassa Fever
| Article | Year |
|---|---|
CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Topics: Animals; Antiviral Agents; Arenaviridae; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chlorocebus aethiops; Humans; Isoquinolines; Lassa Fever; Lassa virus; Lymphocytic choriomeningitis virus; Quinazolines; Receptors, Virus; Vero Cells; Vesicular Stomatitis; Viral Fusion Protein Inhibitors; Virus Internalization | 2021 |
Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
Topics: Antiviral Agents; Cell Line; Ebolavirus; Genistein; Hemorrhagic Fever, Ebola; Humans; Lassa Fever; Lassa virus; Protein Kinase Inhibitors; Quinazolines; Tyrphostins | 2012 |